CHICAGO, ILLINOIS, UNITED STATES OF AMERICA, June 2, 2024 /EINPresswire.com/ -- Massive Bio, a renowned leader in AI-driven oncology solutions and Mika Health, the ...
Innovations in early disease detection are poised to rapidly change health care. AI is already being integrated into the early cancer detection process - and early Alzheimer's tests may be reshaping ...
Biomarker testing has become “increasingly critical” in the care of non-small cell lung cancer.A new investigation into testing rates proved “reassuring” to Kenneth L. Kehl, MD, MPH, assistant ...
Keith W. Roach, MD, is an associate professor of clinical medicine in the division of general medicine at NewYork-Presbyterian. Christopher Kelly, MD, from UNC Health, is a general cardiologist who ...
David P. Carbone, MD, PhD, director of the thoracic oncology center at The Ohio State University in Columbus, discusses the importance of biomarker testing in both lung cancer overall and non–small ...
Daniel Saez, treatment and trials navigator at the GO2 Foundation for Lung Cancer, discusses biomarker testing and precision medicine in lung cancer. Daniel Saez: Biomarker testing is a genetic test ...
CHICAGO--(BUSINESS WIRE)--ASCO Annual Meeting – Massive Bio, a renowned leader in AI-driven oncology solutions and Mika Health, the premier oncology digital therapeutic platform, today announced a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback